Checkmate Pharma is a clinical-stage biopharmaceutical company developing a new approach for cancer immunotherapy. The clinical programs are focused on enabling more people with cancer to benefit from the promise of novel immunotherapies. They leveraging their expertise in the field of CpG oligonucleotides to discover and develop immunotherapies designed to increase the efficacy of existing immunotherapies and to provide new treatment options for patients and their healthcare providers. Checkmate Pharmaceutical was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Checkmate Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Checkmate Pharmaceuticals Inc market cap is $231.4M.
What is the 52-week high for Checkmate Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Checkmate Pharmaceuticals Inc 52 week high is $10.50 as of September 06, 2025.
What is the 52-week low for Checkmate Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Checkmate Pharmaceuticals Inc 52 week low is $2.00 as of September 06, 2025.
What is Checkmate Pharmaceuticals Inc stock price today?
Checkmate Pharmaceuticals Inc stock price today is $10.50.
What was Checkmate Pharmaceuticals Inc stock price yesterday?
Checkmate Pharmaceuticals Inc stock price yesterday was $10.48.
What is the PE ratio of Checkmate Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Checkmate Pharmaceuticals Inc’s P/E ratio is -3.60.
What is the Price-to-Book ratio of Checkmate Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Checkmate Pharmaceuticals Inc P/B ratio is 4.1293.
What is the 50-day moving average of Checkmate Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Checkmate Pharmaceuticals Inc 50-day moving average is $7.44.
